U.S. markets closed

Zoetis Inc. (ZTS)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
165.18-3.06 (-1.82%)
Al cierre: 04:03PM EST
165.68 +0.50 (+0.30%)
Fuera de horario: 07:21PM EST

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Sector(es)Healthcare
IndustriaDrug Manufacturers—Specialty & Generic
Empleados a tiempo completo12,100

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Ms. Kristin C. PeckCEO & Director3.86M7.64M1971
Mr. Wetteny N. JosephExec. VP & CFO2.91MN/D1972
Ms. Heidi C. ChenExec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics1.39M5.56M1967
Mr. Glenn C. DavidExec. VP & Group Pres of U.S. Operations, Global Diagnostics and BioDevices1.9M2.51M1972
Ms. Roxanne LaganoExec. VP and Chief HR Officer & Global OperationsN/DN/D1965
Ms. Wafaa MamilliEVP, Chief Digital & Tech. Officer, Group Pres for China, Brazil and Preci. Animal HealthN/DN/D1967
Mr. Steven FrankVP of Investor RelationsN/DN/DN/D
Mr. William PriceVP & Chief Communications OfficerN/DN/DN/D
Dr. Robert J. Polzer Ph.D.Exec. VP and Pres of R&DN/DN/D1969
Ms. Jeannette Ferran AstorgaExec. VP of Corp. Affairs & Communications and Chief Sustainability OfficerN/DN/D1975
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Gestión corporativa

La calificación ISS Governance QuickScore de Zoetis Inc. a partir del 1 de enero de 2023 es 2. Las puntuaciones principales son Auditoría: 4; Junta: 1; Derechos del accionista: 6; Compensación: 3.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.